Popular Articles
Cellulite Cream

Drug Companies Increasingly Use Medical Science Liaisons
The Wall Street Journal reports that drug companies are increasingly using medical science liaisons: "Pharmaceutical companies are barred by the Food and Drug Administration from promoting unapproved drug uses, called off-label use, but they are using employees called "medical science liaisons," who are often physicians and pharmacists, as a legal way to discuss those uses. Medical science liaisons, who are considered medical rather than sales staff, have greater freedom than salespeople as they visit doctors offices to discuss the science behind a medicine, including unapproved uses." It notes: "The FDA requires traditional sales reps to refer information requests to their employers" medical or scientific staff, MSLs are usually on those staffs."
generic viagra online
UK's NICE Recommends Use Of Erbitux For Metastatic Colorectal Cancer Patients
The United Kingdom"s National Institute for Health and Clinical Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending the use of the drug Erbitux® (cetuximab) in combination with chemotherapy as a first-line treatment for patients with metastatic (advanced) colorectal cancer (mCRC) who have met specific additional criteria(1) - presenting the possibility of potentially curative surgery.(2) The treatment is recommended for patients in whom the cancer has spread only to the liver and who have normal or "wild-type" KRAS tumors.(1) In the UK, a recommendation by NICE is a prerequisite for funding of a medical treatment by the National Health Service.
News of the day
Drop In Access To Abortion Would Reward Antiabortion-Rights Violence, Opinion Piece Says
After the murder last month of Kansas abortion provider George Tiller, "there is a very real danger" that the availability of abortion later in pregnancy "will end in this country -- not after public deliberation, legislative debate and majority vote, but because antiabortion absolutists on the fringe have intimidated and blacklisted doctors and successfully threatened violence against them," Jim Buie, author of the blog The Buie Knife, writes in a Newsweek.com opinion piece. Buie writes that his parents in the early 1950s chose to institutionalize his three-year-old-brother, who was born with severe Down syndrome, after their attempts to care for him left them with "severe emotional distress" and unable "to meet the needs of their healthy children."Buie continues that he "cannot say that the option of a late-term abortion would have been the right one for my parents." However, "some of the arguments advanced by pro-life forces disturb me," he says, especially a "tendency to romanticize, sentimentalize and idealize life with a cute, forever-young Down-syndrome "angel child."" Buie adds, "It"s an argument I find off-putting, especially when it"s espoused by people who have never been through the wringer trying to care for a child whose disability level is on the most severe end of the scale." He continues, "At the same time, it is very disturbing that until recently, the majority of Down-syndrome fetuses were aborted without expectant mothers receiving proper information or support."Because of Tiller"s murder, it is "possible there won"t be any doctors in the country willing to perform" abortion later in pregnancy, "even if prenatal tests indicate severe retardation," according to Buie, who adds that this would mean that "domestic terrorism could win." He concludes, "It would mean that parents like my own would no longer have a choice, and would instead be forced to endure the same harsh realities that were present in the 1950s" (Buie, Newsweek.com, 6/17).
Mental Health

HIV Testing Kits To Be Distributed To Residents In Washington, D.C., This Week

On Wednesday, a national HIV testing campaign called "Don"t?Guess?Test!" is making a "controversial move" by distributing free HIV testing kits that have not been approved by FDA in the lead up to National HIV Testing Day on June 27, the Washington Business Journal reports. The kits have been clinically tested and are available in Africa, Asia and Europe, according to the Business Journal. Due to the sensitive nature of the non-FDA-approved kits, campaign officials are not disclosing how many tests will be distributed or the location of distribution at this time (Plumb, Washington Business Journal, 6/22). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):